MiniMed Announces Date for Fiscal Year 2027 Second Quarter Financial Results
MiniMed Group, Inc. has scheduled the release of its financial results for the second quarter of fiscal year 2027 for November 24, 2026.
Stocks · News reference
Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $26 to $28.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
MiniMed Group, Inc. has scheduled the release of its financial results for the second quarter of fiscal year 2027 for November 24, 2026.
MiniMed Group, Inc. has announced the appointment of Dr. David Segal to the position of Chief Medical Officer.
Cramer favors McKesson and Medtronic, while avoiding X-Energy and Cipher; he says Vishay is overpriced and advises waiting for a dip.
Dutch Bros, SoundHoundAI, Kohl's and Ondas are among the top ten most-heavily shorted stocks in the market right now.